Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Dermatitis, Atopic × dupilumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Lymphoma, Follicular 1 Dermatitis, Atopic 1 Breast Neoplasms 1

Interventions

itepekimab 2 dupilumab 1 abrocitinib 1 Broncho-Vaxom 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03736967 2021-11-01

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

Regeneron Pharmaceuticals

Phase 2 Terminated

206 enrolled 34 charts

Dermatitis, Atopic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡